Cedar Wealth Management, LLC Amgen Inc Transaction History

Cedar Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $393,821 - $438,255	-1,707 Reduced 77.41%	498 $121,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $47,581 - $52,637	217 Added 10.92%	2,205 $533,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $385,628 - $441,316	1,939 Added 3957.14%	1,988 $447,000
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $10,681 - $13,107	-54 Reduced 52.43%	49 $12,000
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $8,929 - $11,843	49 Added 90.74%	103 $21,000
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $9,401 - $11,265	54 New	54 $10,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cedar Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Wealth Management, LLC with notifications on news.